NO20090289L - Inhibitorer av akt (proteinkinase B) - Google Patents

Inhibitorer av akt (proteinkinase B)

Info

Publication number
NO20090289L
NO20090289L NO20090289A NO20090289A NO20090289L NO 20090289 L NO20090289 L NO 20090289L NO 20090289 A NO20090289 A NO 20090289A NO 20090289 A NO20090289 A NO 20090289A NO 20090289 L NO20090289 L NO 20090289L
Authority
NO
Norway
Prior art keywords
protein kinase
act inhibitors
inhibitors
act
compounds
Prior art date
Application number
NO20090289A
Other languages
English (en)
Norwegian (no)
Inventor
Christopher Randall Schmid
Michael R Myers
Renhua Li
Sajan Joseph
Aktham Aburub
Jenny Pingqi Dai
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of NO20090289L publication Critical patent/NO20090289L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05Phenols
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/472Non-condensed isoquinolines, e.g. papaverine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • AIDS & HIV (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
NO20090289A 2006-06-20 2009-01-19 Inhibitorer av akt (proteinkinase B) NO20090289L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US80526006P 2006-06-20 2006-06-20
US88576507P 2007-01-19 2007-01-19
PCT/US2007/070945 WO2007149730A2 (en) 2006-06-20 2007-06-12 Inhibitors of akt (protein kinase b)

Publications (1)

Publication Number Publication Date
NO20090289L true NO20090289L (no) 2009-01-19

Family

ID=38834248

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20090289A NO20090289L (no) 2006-06-20 2009-01-19 Inhibitorer av akt (proteinkinase B)

Country Status (28)

Country Link
US (1) US7998977B2 (ja)
EP (1) EP2035385B1 (ja)
JP (1) JP2009541335A (ja)
KR (1) KR101067551B1 (ja)
AR (1) AR061240A1 (ja)
AT (1) ATE455102T1 (ja)
AU (1) AU2007261120A1 (ja)
BR (1) BRPI0713136A2 (ja)
CA (1) CA2652612A1 (ja)
CL (1) CL2007001752A1 (ja)
DE (1) DE602007004333D1 (ja)
DK (1) DK2035385T3 (ja)
DO (1) DOP2008000053A (ja)
EA (1) EA015712B1 (ja)
EC (1) ECSP088992A (ja)
ES (1) ES2336630T3 (ja)
HR (1) HRP20100147T1 (ja)
IL (1) IL195005A0 (ja)
MA (1) MA30757B1 (ja)
MX (1) MX2008015904A (ja)
NO (1) NO20090289L (ja)
PE (1) PE20080338A1 (ja)
PL (1) PL2035385T3 (ja)
PT (1) PT2035385E (ja)
SI (1) SI2035385T1 (ja)
TN (1) TNSN08529A1 (ja)
TW (1) TW200812970A (ja)
WO (1) WO2007149730A2 (ja)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8217047B2 (en) 2008-05-27 2012-07-10 Dmi Acquisition Corp. Therapeutic methods and compounds
EP2613786A4 (en) 2010-09-07 2013-10-23 Dmi Acquisition Corp TREATMENT OF DISEASES
MX2014003856A (es) 2011-10-10 2015-01-16 Ampio Pharmaceuticals Inc Dispositivos medicos implantables con tolerancia inmune incrementada y metodos para hacerlos e implantarlos.
EP3721884A1 (en) 2011-10-10 2020-10-14 Ampio Pharmaceuticals, Inc. Treatment of degenerative joint disease with da-dkp (= aspartyl-alanyl diketopiperazine)
EP2771007B1 (en) 2011-10-28 2018-04-04 Ampio Pharmaceuticals, Inc. Treatment of rhinitis
US9808454B2 (en) 2013-03-15 2017-11-07 Ampio Pharmaceuticals, Inc. Compositions for the mobilization, homing, expansion and differentiation of stem cells and methods of using the same
KR20160099081A (ko) 2013-07-26 2016-08-19 업데이트 파마 인코포레이트 비산트렌의 치료 효과 개선용 조합 방법
KR20170045274A (ko) 2014-08-18 2017-04-26 앰피오 파마슈티컬스 인코퍼레이티드 관절 징후의 치료
WO2016201605A1 (zh) * 2015-06-15 2016-12-22 廖勇 一种治疗乙型肝炎病毒的靶点
WO2016209969A1 (en) 2015-06-22 2016-12-29 Ampio Pharmaceuticals, Inc. Use of low molecular weight fractions of human serum albumin in treating diseases
WO2017156350A1 (en) 2016-03-09 2017-09-14 K-Gen, Inc. Methods of cancer treatment
CA3186562A1 (en) * 2020-07-22 2022-01-27 Jian Wu Salt and crystal form of dihydropyrido[2,3-d]pyrimidine derivate

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL152807A0 (en) 2000-05-30 2003-06-24 Peptor Ltd Protein kinase inhibitors
US7414063B2 (en) * 2003-03-28 2008-08-19 Eli Lilly And Company Inhibitors of Akt (protein kinase B)
GB0317315D0 (en) 2003-07-24 2003-08-27 Astex Technology Ltd Pharmaceutical compounds
US7449477B2 (en) 2003-11-25 2008-11-11 Eli Lilly And Company 7-phenyl-isoquinoline-5-sulfonylamino derivatives as inhibitors of akt (protein kinase B)

Also Published As

Publication number Publication date
PT2035385E (pt) 2010-03-01
SI2035385T1 (sl) 2010-05-31
JP2009541335A (ja) 2009-11-26
EP2035385A2 (en) 2009-03-18
US7998977B2 (en) 2011-08-16
BRPI0713136A2 (pt) 2012-04-17
CL2007001752A1 (es) 2008-01-18
MX2008015904A (es) 2009-01-12
TNSN08529A1 (en) 2010-04-14
DE602007004333D1 (de) 2010-03-04
AR061240A1 (es) 2008-08-13
IL195005A0 (en) 2009-08-03
WO2007149730A2 (en) 2007-12-27
AU2007261120A1 (en) 2007-12-27
CA2652612A1 (en) 2007-12-27
PL2035385T3 (pl) 2010-06-30
TW200812970A (en) 2008-03-16
WO2007149730A3 (en) 2008-04-24
ATE455102T1 (de) 2010-01-15
ES2336630T3 (es) 2010-04-14
MA30757B1 (fr) 2009-10-01
DOP2008000053A (es) 2009-01-15
EA015712B1 (ru) 2011-10-31
EP2035385B1 (en) 2010-01-13
DK2035385T3 (da) 2010-03-22
PE20080338A1 (es) 2008-04-25
EA200970041A1 (ru) 2009-06-30
KR101067551B1 (ko) 2011-09-27
KR20090015978A (ko) 2009-02-12
HRP20100147T1 (hr) 2010-04-30
ECSP088992A (es) 2009-01-30
US20090221633A1 (en) 2009-09-03

Similar Documents

Publication Publication Date Title
NO20090289L (no) Inhibitorer av akt (proteinkinase B)
NO2020010I1 (no) fostamatinib eller et farmasøytisk akseptabelt salt av fostamatinib, eller et hydrat, solvat eller N-oksid av fostamatinib eller det farmasøytisk akseptable saltet av fostamatinib, spesielt fostamatinib dinatrium, eventuelt på form av et hydrat
NO20081569L (no) Administrasjon av dipeptidylpeptildaseinhibitorer
DK1483265T3 (da) Purinderivater som kinaseinhibitorer
NO20082090L (no) Pyridopyrimidinoninhibitorer av P13K alfa
NO20053470L (no) Triazolopyridaziner som proteinkinase-inhibitorer
DK1658292T3 (da) Triazologyrimidinderivater som glycogensynthasekinase 3 - inhibitorer
SE0400284D0 (sv) Novel compounds
DK1711481T4 (da) Krystallinsk monohydrat som kinaseinhibitorer
DK1585749T3 (da) Diazepinoindol-derivater som kinaseinhibitorer
MX2009002010A (es) Derivados de heteroarilo como inhibidores de la proteina cinasa.
NO20082482L (no) Karbonylamino pyrrolpyrazoler, samt anvendelse som kinase inhibitorer
NO20051100L (no) Pyrazolsammensetninger anvendelige som GSK-3-inhibitorer
UY30298A1 (es) Inhibidores de la quinasa c-fms ii
NO20052888D0 (no) Diamintriazoler anvendelige som inhibitorer av proteinkinaser
DK1786785T3 (da) Enantiomerisk rene aminoheteroaryl-forbindelser som proteinkinasehæmmere
RS52979B (en) INHIBITORI P38 MAP KINAZE
AR062745A1 (es) 2-[4-(7-etil-5h-pirrolo[2,3-b]pirazin-6-il)-fenil]-propan-2-ol como inhibidor de quinasa
HK1133012A1 (en) Pyrimidinones as casein kinase ii (ck2) modulators
NO20090346L (no) Pyrazolderivater som inhibitorer av cytokrom P450
ATE479687T1 (de) Kinaseinhibitoren
PL1899329T3 (pl) Pirymidyno-podstawione pochodne benzimidazolu jako inhibitory kinaz białkowych
WO2008017932A3 (en) Heterocycles useful as inhibitors of carbonic anhydrase
EA200870448A1 (ru) Тризамещенные 1,2,4-триазолы
NO20082256L (no) Pyrazolderivater, preparater som inneholder slike forbindelser, og fremgangsmåter for anvendelse

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application